Sunday, October 25, 2020 8:08:55 PM
Recent CLDX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 08:07:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 08:01:15 PM
- Celldex Reports First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/06/2024 08:01:00 PM
- Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria • GlobeNewswire Inc. • 04/17/2024 12:01:00 PM
- Celldex Therapeutics to Participate in the Leerink Partners Global Biopharma Conference • GlobeNewswire Inc. • 03/08/2024 12:00:00 PM
- Celldex Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference • GlobeNewswire Inc. • 03/05/2024 03:30:00 PM
- Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares • GlobeNewswire Inc. • 03/05/2024 03:10:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 09:10:02 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/01/2024 09:09:03 PM
- Celldex Therapeutics Announces Pricing of Upsized $400 Million Public Offering of Common Stock • GlobeNewswire Inc. • 03/01/2024 02:14:47 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/28/2024 09:10:14 PM
- Celldex Therapeutics Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 02/28/2024 09:01:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/26/2024 01:18:41 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2024 12:05:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 12:01:57 PM
- Celldex Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 02/26/2024 12:01:00 PM
- Celldex Therapeutics Presents Positive 12 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria • GlobeNewswire Inc. • 02/24/2024 07:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:05:55 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:17:46 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 05:52:38 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 04:48:51 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 12:38:19 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/13/2024 02:41:22 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/08/2024 03:11:32 PM
- Celldex to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference • GlobeNewswire Inc. • 02/06/2024 09:01:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM